DXCM vs TTI · P/E 63, rev $4.03B vs P/E 170, $1.50B cap
DexCom Inc (DXCM) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
TTI does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the DXCM and TTI stock pages for the full models.
Not investment advice.